We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA OK for ‘Phantom Recall’ Would Not Excuse J&J, House Says
FDA OK for ‘Phantom Recall’ Would Not Excuse J&J, House Says
September 28, 2010
Johnson & Johnson (J&J) will not be excused for ‘trying to pull a fast one’ with its so-called phantom recall of Motrin, even if the FDA had given it permission for a product removal instead of an official recall, a House committee says.